FDA Grants SeaStar Medical’s Selective Cytopheretic Device Breakthrough Device Designation for Hepatorenal Syndrome

Press/Media

Period	19 Oct 2023

Media coverage

Title	FDA Grants SeaStar Medical’s Selective Cytopheretic Device Breakthrough Device Designation for Hepatorenal Syndrome
Media name/outlet	NS Medical Devices
Country/Territory	United Kingdom
Date	19/10/23
URL	ct.moreover.com/?a=52106123608&p=1gw&v=1&x=MSBzDwPgsA2mgXMatfcu7Q
Persons	Kevin Chung